ID U266B1 AC CVCL_0566 SY U266-B1; U266 B1; U-266; U 266; U266; U266S; U266BL; U266 Bl; 266 Bl DR BTO; BTO_0001594 DR CLO; CLO_0009457 DR CLO; CLO_0009458 DR EFO; EFO_0001254 DR MCCL; MCC:0000471 DR CLDB; cl4584 DR CLDB; cl4609 DR ArrayExpress; E-MTAB-38 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-2706 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR ArrayExpress; E-MTAB-7721 DR ArrayExpress; E-MTAB-7722 DR ArrayExpress; E-TABM-937 DR ATCC; TIB-196 DR BCRC; 60437 DR BCRJ; 0240 DR BioSample; SAMN01821605 DR BioSample; SAMN01821669 DR BioSample; SAMN03472935 DR BioSample; SAMN10987866 DR cancercelllines; CVCL_0566 DR CCRID; 1101HUM-PUMC000684 DR CCRID; 4201HUM-CCTCC00325 DR CCTCC; GDC0301 DR CCTCC; GDC0325 DR Cell_Model_Passport; SIDM00417 DR CGH-DB; 37-1 DR CGH-DB; 9155-4 DR ChEMBL-Cells; CHEMBL3308535 DR ChEMBL-Targets; CHEMBL2366315 DR CLS; 300259 DR Cosmic; 720795 DR Cosmic; 742953 DR Cosmic; 753615 DR Cosmic; 759903 DR Cosmic; 759912 DR Cosmic; 760401 DR Cosmic; 760647 DR Cosmic; 886087 DR Cosmic; 888019 DR Cosmic; 991555 DR Cosmic; 1424220 DR Cosmic; 1483078 DR Cosmic; 1762463 DR Cosmic; 1889513 DR Cosmic; 2081409 DR Cosmic; 2159571 DR Cosmic; 2367281 DR Cosmic; 2391806 DR Cosmic; 2809754 DR Cosmic-CLP; 753615 DR DepMap; ACH-000626 DR DSMZ; ACC-9 DR DSMZCellDive; ACC-9 DR ECACC; 85051003 DR EGA; EGAS00001000610 DR EGA; EGAS00001000978 DR EGA; EGAS00001002554 DR GDSC; 753615 DR GEO; GSM143345 DR GEO; GSM545498 DR GEO; GSM545499 DR GEO; GSM562821 DR GEO; GSM827442 DR GEO; GSM887721 DR GEO; GSM888815 DR GEO; GSM1374970 DR GEO; GSM1670556 DR IARC_TP53; 361 DR IARC_TP53; 30185 DR IBRC; C10148 DR IGRhCellID; U266B1 DR IZSLER; BS TCL 233 DR KCB; KCB 2013024YJ DR LiGeA; CCLE_465 DR LINCS_LDP; LCL-2050 DR Lonza; 106 DR Lonza; 807 DR NCBI_Iran; C151 DR PharmacoDB; U266B1_1630_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_0566 DR PubChem_Cell_line; CVCL_0566 DR Wikidata; Q54973634 RX CelloPub=CLPUB00604; RX DOI=10.1007/0-306-46877-8_4; RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=1373872; RX PubMed=1643757; RX PubMed=1720489; RX PubMed=2140233; RX PubMed=2537114; RX PubMed=2985879; RX PubMed=3159941; RX PubMed=3874327; RX PubMed=4097745; RX PubMed=4104421; RX PubMed=6350451; RX PubMed=8943038; RX PubMed=9685479; RX PubMed=10087940; RX PubMed=10557056; RX PubMed=10583232; RX PubMed=10936422; RX PubMed=11154231; RX PubMed=11157491; RX PubMed=11429052; RX PubMed=14555701; RX PubMed=15215163; RX PubMed=16956823; RX PubMed=17171682; RX PubMed=17229644; RX PubMed=17692805; RX PubMed=18647998; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=21173094; RX PubMed=22460905; RX PubMed=22806891; RX PubMed=23074853; RX PubMed=23992230; RX PubMed=25485619; RX PubMed=25688540; RX PubMed=25877200; RX PubMed=26589293; RX PubMed=27397505; RX PubMed=28196595; RX PubMed=30285677; RX PubMed=30545397; RX PubMed=30894373; RX PubMed=31068700; RX PubMed=31160637; RX PubMed=32123307; RX PubMed=35839778; WW Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Group: Hybridoma fusion partner cell line. CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Part of: LL-100 blood cancer cell line panel. CC Part of: MD Anderson Cell Lines Project. CC Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). CC Population: Caucasian. CC Characteristics: Produces IgE lambda. CC Doubling time: 108-144 hours (PubMed=4104421); ~55 hours (DSMZ=ACC-9). CC HLA typing: A*02:01,03; B*07,40; C*03:04,07 (Direct_author_submission). CC HLA typing: A*02:01,03:01; B*07:02,40:01; C*03:04,07:02 (PubMed=26589293). CC HLA typing: A*02:01:01;03:01:01; B*07:02:01,40:01:02; C*03:04:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,02:01:02; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRA*01:02:02,01:02:03; DRB1*03:01:01,15:01:01 (DSMZCellDive=ACC-9). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (Cosmic-CLP=753615; DepMap=ACH-000626). CC Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (Cosmic-CLP=753615; DepMap=ACH-000626). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=1373872; PubMed=21173094; Cosmic-CLP=753615; DepMap=ACH-000626). CC Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (PubMed=17692805). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; Array-based CGH. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0%; Native American=0%; East Asian, North=2.78%; East Asian, South=0.29%; South Asian=0.45%; European, North=80.76%; European, South=15.72% (PubMed=30894373). CC Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine. CC Discontinued: BCRJ; 0240; probable. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: Plasma cell; CL=CL_0000786. ST Source(s): ATCC=TIB-196; CCRID; CLS=300259; Cosmic-CLP=753615; DSMZ=ACC-9; ECACC=85051003; PubMed=25877200; Technion Genomics Center ST Amelogenin: X,Y ST CSF1PO: 12,13 ST D10S1248: 14 ST D12S391: 18 ST D13S317: 12 ST D16S539: 10 ST D18S51: 12,14 ST D19S433: 13,15 ST D1S1656: 12,15 ST D21S11: 28,29 ST D22S1045: 15,16 ST D2S1338: 20,23 ST D2S441: 10,11 ST D3S1358: 17 ST D5S818: 11,12 ST D6S1043: 11,17 ST D7S820: 11,12 ST D8S1179: 13 ST DYS391: 10 ST FGA: 18 ST Penta D: 10,13 ST Penta E: 10,12 ST TH01: 5,7 ST TPOX: 8 ST vWA: 17 DI NCIt; C3242; Plasma cell myeloma DI ORDO; Orphanet_29073; Multiple myeloma OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_JA36 ! U255 OI CVCL_W412 ! U268 SX Male AG 53Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 48 CH CVCL_C833 ! AF10 [Human myeloma] CH CVCL_J235 ! FU-266 CH CVCL_4974 ! SKO-007 CH CVCL_0015 ! U-266/70 CH CVCL_0016 ! U-266/84 CH CVCL_E5J9 ! U266-PSR CH CVCL_GZ72 ! U266/ADM CH CVCL_VJ36 ! U266/BR CH CVCL_T031 ! U266/velR CH CVCL_D5KP ! U266B1-Fluc-EmGFP CH CVCL_D5KQ ! U266B1-Fluc-Puro CH CVCL_C828 ! U266R // RX PubMed=10583232; DOI=10.1046/j.1365-2141.1999.01705.x; RA Puthier, Denis RA Derenne, Sophie RA Barille, Sophie RA Moreau, Philippe RA Harousseau, Jean-Luc RA Bataille, Francois-Regis RA Amiot, Martine RT "Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells."; RL Br. J. Haematol. 107:392-395(1999). // RX PubMed=2537114; DOI=10.1182/blood.V73.2.566.566; RA Duperray, Christophe RA Klein, Bernard RA Durie, Brian G.M. RA Zhang, Xue-Guang RA Jourdan, Michel RA Poncelet, Philippe RA Favier, Francois RA Vincent, Claude RA Brochier, Jean RA Lenoir, Gilbert Marcel RA Bataille, Francois-Regis RT "Phenotypic analysis of human myeloma cell lines."; RL Blood 73:566-572(1989). // RX PubMed=10557056; DOI=10.1038/sj.leu.2401563; RA Yoshida, Shoko RA Nakazawa, Naozo RA Iida, Shinsuke RA Hayami, Yoshihito RA Sato, Shigeki RA Wakita, Atsushi RA Shimizu, Shiro RA Taniwaki, Masafumi RA Ueda, Ryuzo RT "Detection of MUM1/IRF4-IgH fusion in multiple myeloma."; RL Leukemia 13:1812-1816(1999). // RX DOI=10.1007/0-306-46877-8_4; RA Jernberg-Wiklund, Helena RA Nilsson, Kenneth RT "Multiple myeloma cell lines."; RL (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=14555701; RA Shammas, Masood A. RA Shmookler Reis, Robert Joseph RA Akiyama, Masaharu RA Koley, Hemanta RA Chauhan, Dharminder RA Hideshima, Teru RA Goyal, Raj K. RA Hurley, Laurence H. RA Anderson, Kenneth Carl RA Munshi, Nikhil C. RT "Telomerase inhibition and cell growth arrest by G-quadruplex RT interactive agent in multiple myeloma."; RL Mol. Cancer Ther. 2:825-833(2003). // RX PubMed=23992230; DOI=10.1111/ejh.12192; PMCID=PMC3834223; RA Greenberg, Alexandra J. RA Walters, Denise K. RA Kumar, Shaji K. RA Rajkumar, S. Vincent RA Jelinek, Diane F. RT "Responsiveness of cytogenetically discrete human myeloma cell lines RT to lenalidomide: lack of correlation with cereblon and interferon RT regulatory factor 4 expression levels."; RL Eur. J. Haematol. 91:504-513(2013). // RX PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646; RA Quentmeier, Hilmar RA Pommerenke, Claudia RA Dirks, Wilhelm Gerhard RA Eberth, Sonja RA Koeppel, Max RA MacLeod, Roderick A.F. RA Nagel, Stefan RA Steube, Klaus G. RA Uphoff, Cord C. RA Drexler, Hans Gunther RT "The LL-100 panel: 100 cell lines for blood cancer studies."; RL Sci. Rep. 9:8218.1-8218.14(2019). // RX PubMed=23074853; DOI=10.1134/S1990519X12050136; RA Turilova, Victoria I. RA Smirnova, Tatyana Dmitriyevna RT "Karyotypic variability of human myeloma cell lines."; RL Tsitologiia 54:621-636(2012). // RX PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- III. RT Beta-hexosaminidase (E.C. 3.2.1.30)."; RL Leuk. Res. 9:549-559(1985). // RX PubMed=16956823; RA Bataille, Francois-Regis RA Jego, Gaatan RA Robillard, Nelly RA Barille-Nion, Sophie RA Harousseau, Jean-Luc RA Moreau, Philippe RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "The phenotype of normal, reactive and malignant plasma cells. RT Identification of 'many and multiple myelomas' and of new targets for RT myeloma therapy."; RL Haematologica 91:1234-1240(2006). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=11154231; DOI=10.1182/blood.V97.2.516; RA Hjertner, Oyvind RA Hjorth-Hansen, Henrik RA Borset, Magne RA Seidel, Carina RA Waage, Anders RA Sundan, Anders RT "Bone morphogenetic protein-4 inhibits proliferation and induces RT apoptosis of multiple myeloma cells."; RL Blood 97:516-522(2001). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, Agda Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=11157491; DOI=10.1182/blood.V97.3.729; RA Chesi, Marta RA Brents, Leslie A. RA Ely, Sarah A. RA Bais, Carlos RA Robbiani, Davide F. RA Mesri, Enrique A. RA Kuehl, Walter Michael RA Bergsagel, Peter Leif RT "Activated fibroblast growth factor receptor 3 is an oncogene that RT contributes to tumor progression in multiple myeloma."; RL Blood 97:729-736(2001). // RX PubMed=17692805; DOI=10.1016/j.ccr.2007.07.003; PMCID=PMC2083698; RA Keats, Jonathan J. RA Fonseca, Rafael RA Chesi, Marta RA Schop, Roelandt RA Baker, Angela RA Chng, Wee-Joo RA Van Wier, Scott RA Tiedemann, Rodger RA Shi, Chang-Xin RA Sebag, Michael RA Braggio, Esteban RA Henry, Travis RA Zhu, Yuan-Xiao RA Fogle, Homer RA Price-Troska, Tammy L. RA Ahmann, Gregory J. RA Mancini, Catherine RA Brents, Leslie A. RA Kumar, Shaji K. RA Greipp, Philip Robert RA Dispenzieri, Angela RA Bryant, Barb RA Mulligan, George RA Bruhn, Laurakay RA Barrett, Michael T. RA Valdez, Riccardo RA Trent, Jeffrey M. RA Stewart, A. Keith RA Carpten, John D. RA Bergsagel, Peter Leif RT "Promiscuous mutations activate the noncanonical NF-kappaB pathway in RT multiple myeloma."; RL Cancer Cell 12:131-144(2007). // RX PubMed=4104421; DOI=10.1002/ijc.2910070303; RA Nilsson, Kenneth RT "Characteristics of established myeloma and lymphoblastoid cell lines RT derived from an E myeloma patient: a comparative study."; RL Int. J. Cancer 7:380-396(1971). // RX PubMed=6350451; DOI=10.4049/jimmunol.131.3.1201; RA Abrams, Paul G. RA Knost, James A. RA Clarke, Gregory RA Wilburn, Shannon RA Oldham, Robert K. RA Foon, Kenneth Alan RT "Determination of the optimal human cell lines for development of RT human hybridomas."; RL J. Immunol. 131:1201-1204(1983). // RX PubMed=10087940; DOI=10.1016/S0165-4608(98)00157-5; RA Kuipers, Jeroen RA Vaandrager, Jan Willem RA Weghuis, Danielle Olde RA Pearson, Peter Lees RA Scheres, Jacques RA Lokhorst, Henk Martinus RA Clevers, Hans Cornelius RA Bast, Bert J.E.G. RT "Fluorescence in situ hybridization analysis shows the frequent RT occurrence of 14q32.3 rearrangements with involvement of RT immunoglobulin switch regions in myeloma cell lines."; RL Cancer Genet. Cytogenet. 109:99-107(1999). // RX PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. RT Carboxylic esterase."; RL Leuk. Res. 9:209-229(1985). // RX PubMed=9685479; DOI=10.1093/nar/26.16.3651; PMCID=PMC147775; RA Hultdin, Magnus RA Gronlund, Elisabeth RA Norrback, Karl-Frederik RA Eriksson-Lindstrom, E. RA Just, Tom RA Roos, Goran RT "Telomere analysis by fluorescence in situ hybridization and flow RT cytometry."; RL Nucleic Acids Res. 26:3651-3656(1998). // RX PubMed=8943038; DOI=10.1073/pnas.93.24.13931; PMCID=PMC19472; RA Bergsagel, Peter Leif RA Chesi, Marta RA Nardini, Elena RA Brents, Leslie A. RA Kirby, Suzanne Lee RA Kuehl, Walter Michael RT "Promiscuous translocations into immunoglobulin heavy chain switch RT regions in multiple myeloma."; RL Proc. Natl. Acad. Sci. U.S.A. 93:13931-13936(1996). // RX PubMed=1720489; DOI=10.1016/0145-2126(91)90110-f; RA Suzuki, Akira RA Takahashi, Takayuki RA Okuno, Yoshiaki RA Fukumoto, Manabu RA Fukui, Hiroyasu RA Koishihara, Yasuo RA Ohsugi, Yoshiaki RA Ohno, Yohichiro RA Imura, Hiroo RT "Estimation of interleukin 6 production by reverse RT transcriptase-polymerase chain reaction in four human myeloma cell RT lines."; RL Leuk. Res. 15:1043-1050(1991). // RX PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2; RA Drexler, Hans Gunther RA Matsuo, Yoshinobu RT "Malignant hematopoietic cell lines: in vitro models for the study of RT multiple myeloma and plasma cell leukemia."; RL Leuk. Res. 24:681-703(2000). // RX CelloPub=CLPUB00604; RA Chow, Sharon RT "Targeted capture and sequencing of immunoglobulin rearrangements RT in multiple myeloma to enable detection of minimal residual disease."; RL Thesis MSc (2017); University of Toronto; Toronto; Canada. // RX PubMed=11429052; DOI=10.1111/j.1349-7006.2001.tb01142.x; PMCID=PMC5926752; RA Hanamura, Ichiro RA Iida, Shinsuke RA Akano, Yumiko RA Hayami, Yoshihito RA Kato, Miyuki RA Miura, Kazuhisa RA Harada, Shinsuke RA Banno, Shogo RA Wakita, Atsushi RA Kiyoi, Hitoshi RA Naoe, Tomoki RA Shimizu, Shiro RA Sonta, Shin-ichi RA Nitta, Masakazu RA Taniwaki, Masafumi RA Ueda, Ryuzo RT "Ectopic expression of MAFB gene in human myeloma cells carrying RT (14;20)(q32;q11) chromosomal translocations."; RL Jpn. J. Cancer Res. 92:638-644(2001). // RX PubMed=22806891; DOI=10.1182/blood-2011-08-371567; RA Holien, Toril RA Vatsveen, Thea Kristin RA Hella, Hanne RA Waage, Anders RA Sundan, Anders RT "Addiction to c-MYC in multiple myeloma."; RL Blood 120:2450-2453(2012). // RX PubMed=25485619; DOI=10.1038/nbt.3080; RA Klijn, Christiaan RA Durinck, Steffen RA Stawiski, Eric W. RA Haverty, Peter M. RA Jiang, Zhao-Shi RA Liu, Han-Bin RA Degenhardt, Jeremiah RA Mayba, Oleg RA Gnad, Florian RA Liu, Jin-Feng RA Pau, Gregoire RA Reeder, Jens RA Cao, Yi RA Mukhyala, Kiran RA Selvaraj, Suresh K. RA Yu, Ma-Mie RA Zynda, Gregory J. RA Brauer, Matthew J. RA Wu, Thomas D. RA Gentleman, Robert Clifford RA Manning, Gerard RA Yauch, Robert L. RA Bourgon, Richard RA Stokoe, David RA Modrusan, Zora RA Neve, Richard M. RA de Sauvage, Frederic J. RA Settleman, Jeffrey RA Seshagiri, Somasekar RA Zhang, Ze-Min RT "A comprehensive transcriptional portrait of human cancer cell RT lines."; RL Nat. Biotechnol. 33:306-312(2015). // RX PubMed=30545397; DOI=10.1186/s13045-018-0679-0; PMCID=PMC6293660; RA Tessoulin, Benoit RA Moreau-Aubry, Agnes RA Descamps, Geraldine RA Gomez-Bougie, Patricia RA Maiga, Sophie RA Gaignard, Alban RA Chiron, David RA Menoret, Emmanuelle RA Le Gouill, Steven RA Moreau, Philippe RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "Whole-exon sequencing of human myeloma cell lines shows mutations RT related to myeloma patients at relapse with major hits in the DNA RT regulation and repair pathways."; RL J. Hematol. Oncol. 11:137.1-137.13(2018). // RX PubMed=1643757; DOI=10.1016/0090-1229(92)90205-3; RA Renz, Harald RA Or, Reuven RA Domenico, Joanne RA Leung, Donald Y.M. RA Gelfand, Erwin William RT "Reciprocal regulatory effects of IL-4 on cell growth and RT immunoglobulin production in Ig-secreting human B-cell lines."; RL Clin. Immunol. Immunopathol. 64:233-241(1992). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x; RA Nakano, Akinobu RA Harada, Takayuki RA Morikawa, Shigeru RA Kato, Yuzuru RT "Expression of leukocyte common antigen (CD45) on various human RT leukemia/lymphoma cell lines."; RL Acta Pathol. Jpn. 40:107-115(1990). // RX PubMed=21173094; DOI=10.3324/haematol.2010.033456; PMCID=PMC3069235; RA Moreaux, Jerome RA Klein, Bernard RA Bataille, Francois-Regis RA Descamps, Geraldine RA Maiga, Sophie RA Hose, Dirk RA Goldschmidt, Hartmut RA Jauch, Anna RA Reme, Thierry RA Jourdan, Michel RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "A high-risk signature for patients with multiple myeloma established RT from the molecular classification of human myeloma cell lines."; RL Haematologica 96:574-582(2011). // RX PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786; RA Tan, Kar-Tong RA Ding, Ling-Wen RA Sun, Qiao-Yang RA Lao, Zhen-Tang RA Chien, Wenwen RA Ren, Xi RA Xiao, Jin-Fen RA Loh, Xin-Yi RA Xu, Liang RA Lill, Michael RA Mayakonda, Anand RA Lin, De-Chen RA Yang, Henry He RA Koeffler, Harold Phillip RT "Profiling the B/T cell receptor repertoire of lymphocyte derived cell RT lines."; RL BMC Cancer 18:940.1-940.13(2018). // RX PubMed=15215163; DOI=10.1016/S0002-9440(10)63276-2; PMCID=PMC1618545; RA Inoue, Jun RA Otsuki, Takemi RA Hirasawa, Akira RA Imoto, Issei RA Matsuo, Yoshinobu RA Shimizu, Shiroh RA Taniwaki, Masafumi RA Inazawa, Johji RT "Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be RT associated with drug-resistance phenotype in multiple myeloma."; RL Am. J. Pathol. 165:71-81(2004). // RX PubMed=25688540; DOI=10.1002/cyto.a.22643; RA Maiga, Sophie RA Brosseau, Carole RA Descamps, Geraldine RA Dousset, Christelle RA Gomez-Bougie, Patricia RA Chiron, David RA Menoret, Emmanuelle RA Kervoelen, Charlotte RA Vie, Henri RA Cesbron, Anne RA Moreau-Aubry, Agnes RA Amiot, Martine RA Pellat-Deceunynck, Catherine RT "A simple flow cytometry-based barcode for routine authentication of RT multiple myeloma and mantle cell lymphoma cell lines."; RL Cytometry A 87:285-288(2015). // RX PubMed=32123307; DOI=10.1038/s41375-020-0785-1; PMCID=PMC7483300; RA Sarin, Vishesh RA Yu, Katharine RA Ferguson, Ian D. RA Gugliemini, Olivia RA Nix, Matthew A. RA Hann, Byron RA Sirota, Marina RA Wiita, Arun P. RT "Evaluating the efficacy of multiple myeloma cell lines as models for RT patient tumors via transcriptomic correlation analysis."; RL Leukemia 34:2754-2765(2020). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=17171682; DOI=10.1002/gcc.20404; RA Lombardi, Luigia RA Poretti, Giulia RA Mattioli, Michela RA Fabris, Sonia RA Agnelli, Luca RA Bicciato, Silvio RA Kwee, Ivo RA Rinaldi, Andrea RA Ronchetti, Domenica RA Verdelli, Donata RA Lambertenghi-Deliliers, Giorgio RA Bertoni, Francesco RA Neri, Antonino RT "Molecular characterization of human multiple myeloma cell lines by RT integrative genomics: insights into the biology of the disease."; RL Genes Chromosomes Cancer 46:226-238(2007). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=18647998; DOI=10.1093/jncimonographs/lgn011; PMCID=PMC2737184; RA Dib, Amel RA Gabrea, Ana RA Glebov, Oleg K. RA Bergsagel, Peter Leif RA Kuehl, Walter Michael RT "Characterization of MYC translocations in multiple myeloma cell RT lines."; RL J. Natl. Cancer Inst. Monogr. 39:25-31(2008). // RX PubMed=17229644; DOI=10.3324/haematol.10300; RA Sanda, Takaomi RA Iida, Shinsuke RA Kayukawa, Satoshi RA Ueda, Ryuzo RT "Induction of class II major histocompatibility complex expression in RT human multiple myeloma cells by retinoid."; RL Haematologica 92:115-120(2007). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=4097745; PMCID=PMC1712861; RA Nilsson, Kenneth RA Bennich, Hans RA Johansson, Stig Gunnar Olof RA Ponten, Jan RT "Established immunoglobulin producing myeloma (IgE) and lymphoblastoid RT (IgG) cell lines from an IgE myeloma patient."; RL Clin. Exp. Immunol. 7:477-489(1970). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=1373872; RA Mazars, Georges-Raoul RA Portier, Marielle RA Zhang, Xue-Guang RA Jourdan, Michel RA Bataille, Francois-Regis RA Theillet, Charles RA Klein, Bernard RT "Mutations of the p53 gene in human myeloma cell lines."; RL Oncogene 7:1015-1018(1992). // RX PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid RT phosphatase."; RL Leuk. Res. 9:537-548(1985). //